La réduction des risques dans la région MENA : Où en sommes-nous ?

MENAHRA offre une vue d'ensemble sur l'état de la réduction des risques dans la région et souligne des lacunes dans la recherche, le plaidoyer et la prestation de services. Pour en savoir plus, en Anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

In the past decade, national and international interest in harm reduction in the MENA has increased. As a result, there has been an increase in research, improvements in disease surveillance, and establishment of significant health policies throughout the region.

What needs to be done?

• Scale up advocacy and harm reduction practices. Specifically in countries with a very high prevalence of HIV and large amount of PWIDs, like Egypt, Pakistan and Morocco.

• Improve data collection and surveillance by increasing research and/or collaboration among researchers in order to create usable sets of data. Data is most unreliable or unavailable in Yemen, UAE, Qatar, Iraq, Bahrain, Egypt, Libya, Saudi Arabia, Afghanistan, and Pakistan.

• Scale up surveillance of HCV, HBV, and tuberculosis among PWIDs. These diseases are highly prevalent in certain areas in the region and data is extremely limited